Throughout the past few years, and particularly during the past 12 months, the biolab’s backers have suffered a string of setbacks: legal, diplomatic, political. Boston University Medical Center (BUMC) may still end up hosting a BSL-4 facility, but this is hardly the sure thing it once was. In fact, given the current momentum of the debate, the smart money might actually be on the biolab not coming to fruition, at least as it was originally conceived.
So what went wrong, exactly? Or, for those who see things differently: what went right?
The story chronicles the political side of the biolab debate, with, perhaps, too much attention to race and too little to zombie protesters.
No comments:
Post a Comment